Drugs

Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: What is the Optimal Initiation Time for the Maximum Benefit?
pp. 1-15(15)
Authors: Needleman, Sarah J.; Tobias, Jeffrey S.

Antiepileptic Drug Development in Children: Considerations for a Revisited Strategy
pp. 17-25(9)
Authors: Chiron, Catherine; Dulac, Olivier; Pons, Gerard

Nonresponse to Treatment for Hepatitis C: Current Management Strategies
pp. 27-42(16)
Authors: Yuan, He-Jun; Lee, William M.

Antiretroviral Therapy: Optimal Sequencing of Therapy to Avoid Resistance
pp. 43-72(30)
Authors: Martinez-Cajas, Jorge L.; Wainberg, Mark A.

Pharmacological Treatment of Early Multiple Sclerosis
pp. 73-83(11)
Authors: Stüve, Olaf; Bennett, Jeffrey L.; Hemmer, Bernhard; Wiendl, Heinz; Racke, Michael K.; Bar-Or, Amit; Hu, Wei; Zivadinov, Robert; Weber, Martin S.; Zamvil, Scott S.; Pacheco, Maria F.; Menge, Til; Hartung, Hans-Peter; Kieseier, Bernd C.; Frohman, Elliot M.

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis
pp. 85-104(20)
Authors: Goldsmith, David R.; Scott, Lesley J.; Cvetković, Risto S.; Plosker, Greg L.

Parnaparin: A Review of its Use in the Management of Venous Thromboembolism, Chronic Venous Disease and Other Vascular Disorders
pp. 105-122(18)
Authors: McKeage, Kate; Keating, Gillian M.

Diclofenac Sodium Injection (Dyloject®): In Postoperative Pain
pp. 123-130(8)
Authors: McCormack, Paul L.; Scott, Lesley J.

Raltegravir
pp. 131-138(8)
Authors: Croxtall, Jamie D.; Lyseng-Williamson, Katherine A.; Perry, Caroline M.